Bart Leroy (Ghent University Hospital, Belgium) gave us an update on the latest developments on retinal gene therapy from EURETINA 2019, and shared some patient experiences with the treatment so far.
1. What are the main challenges of diagnosing and treating patients with inherited retinal diseases? 0:03
2. Can you give us an overview of the key sessions around retinal gene therapy at EURETINA 2019? 1:37
3. How have retinal gene therapies been received by patients? 5:57
Support: No funding was received in the production of this video.
Disclosures: Bart Leroy reports work with Novartis, Bayer, Second Sight and other companies that finance research in his hospital but has no personal financial interest.
Share this Video
Related Videos In Retina/Vitreous
Roxane Hillier, EURETINA 2021: Retinal Recovery after Pneumatic Retinopexy
We were delighted to catch up with Roxane Hillier (Newcastle Eye Centre, Newcastle, UK), who gave us her insights on the impact of pneumatic retinopexy (PnR) on vision-related quality of life, and retinal recovery following PnR. Questions What is the impact of pneumatic retinopexy (PnR) on vision-related quality of life? (00:13) What is known about […]
Roxane Hillier, EURETINA 2021: Pneumatic Retinopexy for the Management of Rhegmatogenous Retinal Detachment
It was wonderful to speak with Roxane Hillier (Newcastle Eye Centre, Newcastle, UK) about the advantages of pneumatic retinopexy compared with pars plana vitrectomy for the management of rhegmatogenous retinal detachment. Questions Why has the optimal surgical technique for the treatment of rhegmatogenous retinal detachment (RRD) been controversial? (00:12) What are the advantages of pneumatic […]
Paisan Ruamviboonsuk, EURETINA 2021: Artificial Intelligence Platforms for Diagnosis and Screening for Polypoidal Choroidal Vasculopathy
We enjoyed catching up with Paisan Ruamviboonsuk (Rajavithi Hospital, Bangkok, Thailand) about the clinical evidence supporting the use of artificial intelligence platforms in diagnosis and screening for polypoidal choroidal vasculopathy, and the unanswered questions that remain. Questions What clinical evidence supports the use of artificial intelligence platforms in the diagnosis and screening for polypoidal choroidal […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!